LYCOS RETRIEVER
Birth Defect: National Birth Defect
built 641 days ago
To further assess a possible association between exposure to Claritin and the occurrence of hypospadias, the CDC (Centers for Disease Control and Prevention) have analyzed data from their National Birth Defects Prevention Study. Exposure to Claritin was defined in this study as any maternal use of the drug from a month before pregnancy through the end of the first trimester (through the third month of pregnancy).
Source:
A national organization of individuals working at the local, state, and national level working in birth defects surveillance, research, and prevention. Site offers organizational information, newsletter, and related links to state birth defects monitoring programs and national organizations.
Source: